课题基金 / 基金详情

Role of Lysozyme in Airways Host Defense

Role of Lysozyme in Airways Host Defense
溶菌酶在气道宿主防御中的作用
批准号:
6693825
负责人:
HENRY T AKINBI
金额:
$33.3万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-15 至 2007-01-31

项目摘要

项目成果

HENRY T AKINBI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lysozyme is a cationic protein of 146 amino acid residues (Mr approximately 14k) that is bactericidal against multiple gram-positive bacteria in vitro. Although lysozyme is the most abundant antimicrobial protein in airway surface fluid (ASL), its role in protecting the airways against infection, chronic colonization, and inflammation in vivo remains unproven. The results of preliminary studies reported in this application demonstrate a dose-dependent relationship between the level of lysozyme activity in bronchoalveolar lavage fluid and the rate of bacterial killing, of both gram positive and negative organisms, in acutely infected transgenic mice that overexpress lysozyme. Studies proposed in this application will test the central hypothesis that lysozyme is a critical component of airway host defense in vivo. Pathogen killing will be assessed in lysozyme (-/-) mice and lysozyme overexpressing mice following acute and chronic lung infection. The antimicrobial spectrum and potency of exogenously-administered recombinant lysozyme protein will also be assessed. These studies will provide insight into the role of lysozyme in airway host defense and provide a preliminary assessment of the therapeutic potential of exogenously administered lysozyme.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Lysozyme in Airways Host Defense
Role of Lysozyme in Airways Host Defense
Role of Lysozyme in Airways Host Defense
Role of Lysozyme in Airways Host Defense
海外基金